Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 5, 2012, Pages 935-944

  Long, Yanqin ^a,b   Wang, Wenfeng ^a   Wang, Huan ^a   Hao, Liangcheng ^a   Qian, Wei ^a   Hou, Xiaohua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Dendritic cells; Infection; Irritable bowel syndrome; Trichinella spiralis

Indexed keywords

CD86 ANTIGEN; CYTOKINE;

ABDOMINAL REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPOSITION; CELL ISOLATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; ENTERITIS; FLOW CYTOMETRY; HYPERALGESIA; IRRITABLE COLON; LAMINA PROPRIA; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PATHOGENESIS; POSTINFECTIOUS IRRITABLE BOWEL SYNDROME; PRIORITY JOURNAL; TH2 CELL; TRICHINELLA SPIRALIS;

EID: 84860255599     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07046.x     Document Type: Article

References (50)

1. Drossman D, Camilleri M, Mayer E, Whitehead W. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
2. Gershon M. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 2005; 39: S184.
3. Talley N, Zinsmeister A, Melton L. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am. J. Epidemiol. 1995; 142: 76-83.
4. Longstreth G, Yao J. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-73.
5. Collins S, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001; 49: 743-5.
6. Wang L, Fang X, Pan G. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
7. Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972-9.
8. Chaudhary N, Truelove S. The irritable colon syndrome a study of the clinical features, predisposing causes, and prognosis in 130 cases. Q. J. Med. 1962; 31: 307-22.
9. Ji S, Park H, Lee D, Song Y, Choi J, Lee S. Post-infectious irritable bowel syndrome in patients with Shigella infection. J. Gastroenterol. Hepatol. 2005; 20: 381-6.
10. Neal K, Barker L, Spiller R. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002; 51: 410-13.
11. Spiller R. Role of infection in irritable bowel syndrome. J. Gastroenterol. 2007; 42: 41-7.
12. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 445-50.
13. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010; 59: 605-11.
14. Chadwick V, Chen W, Shu D etal. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
15. O'Sullivan C, Clayton N, Breslin H etal. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol. Motil. 2000; 12: 449-57.
16. Spiller R, Jenkins D, Thornley J etal. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
17. Gwee K, Collins S, Read N etal. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 523-6.
18. Bueno L, Fioramonti J. Effects of inflammatory mediators on gut sensitivity. Can. J. Gastroenterol. 1999; 13: 42A-6A.
19. Steinman R, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-26.
20. Coombes J, Powrie F. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 2008; 8: 435-46.
21. Takenaka S, Safroneeva E, Xing Z, Gauldie J. Dendritic cells derived from murine colonic mucosa have unique functional and phenotypic characteristics. J. Immunol. 2007; 178: 7984-93.
22. Johansson C, Kelsall B. Phenotype and function of intestinal dendritic cells. Semin. Immunol. 2005; 17: 284-94.
23. Hart A, Al-Hassi H, Rigby R etal. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005; 129: 50-65.
24. Silva M, Lopez C, Riverin F, Oligny L, Menezes J, Seidman E. Characterization and distribution of colonic dendritic cells in Crohn's disease. Inflamm. Bowel Dis. 2004; 10: 504-12.
25. Barbara G, Vallance B, Collins S. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 1224-32.
26. Bercik P, Wang L, Verdú E etal. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004; 127: 179-87.
27. Castro G, Fairbairn D. Carbohydrates and lipids in Trichinella spiralis larvae and their utilization in vitro. J. Parasitol. 1969; 55: 51-8.
28. Al-Chaer E, Kawasaki M, Pasricha P. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-85.
29. Jones R, Otsuka E, Wagstrom E, Jensen C, Price M, Gebhart G. Short-term sensitization of colon mechanoreceptors is associated with long-term hypersensitivity to colon distention in the mouse. Gastroenterology 2007; 133: 184-94.
30. Johansson-Lindbom B, Svensson M, Pabst O etal. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 2005; 202: 1063-73.
31. Krajina T, Leithauser F, Moller P, Trobonjaca Z, Reimann J. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur. J. Immunol. 2003; 33: 1073-83.
32. Adema G, Hartgers F, Verstraten R etal. A dendritic-cell-derived CC chemokine that preferentially attracts naive T cells. Nature 1997; 383: 713-17.
33. Tang H, Cyster J. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284: 819-22.
34. Karlis J, Penttila I, Tran T etal. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm. Bowel Dis. 2004; 10: 834-47.
35. Drakes M, Blanchard T, Czinn S. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J. Leukoc. Biol. 2005; 78: 1291-300.
36. Talley N, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-64.
37. Sukhdeo M, Croll N. Gut propulsion in mice infected with Trichinella spiralis. J. Parasitol. 1981; 67: 906-10.
38. Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins S. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 2005; 129: 131-41.
39. Wheatcroft J, Wakelin D, Smith A, Mahoney C, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol. Motil. 2005; 17: 863-70.
40. Uematsu S, Fujimoto K, Jang M etal. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008; 9: 769-76.
41. Cruickshank S, Deschoolmeester M, Svensson M etal. Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection. J. Immunol. 2009; 182: 3055-62.
42. Ikeda Y, Akbar F, Matsui H, Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2001; 13: 841-50.
43. Kelleher P, Maroof A, Knight S. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur. J. Immunol. 1999; 29: 2309-18.
44. Woo A, Gildea L, Tack L etal. In vivo evidence for IFN-γ mediated homeostatic mechanisms in small intestine of the NHE3Na/H exchanger knockout model of congenital diarrhea. J. Biol. Chem. 2002; 277: 49036-46.
45. Harrington L, Hatton R, Mangan P etal. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005; 6: 1123-32.
46. Veldhoen M, Hocking R, Atkins C, Locksley R, TG SB. F-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-89.
47. Bettelli E, Carrier Y, Gao W etal. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
48. Kobayashi T, Okamoto S, Hisamatsu T etal. IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008; 57: 1682-9.
49. Baumgart D, Carding S. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-40.
50. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58: 1152-67.